The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of KN046 plus nab-paclitaxel/gemcitabine as first-line treatment for unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).
 
Gang Jin
No Relationships to Disclose
 
Shiwei Guo
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Yue Ma
No Relationships to Disclose
 
Xiaodong Guo
No Relationships to Disclose
 
Xiaocui Zhou
No Relationships to Disclose
 
Qin Yu
No Relationships to Disclose